Regenerative Medicine Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABBV | D | AbbVie Inc. | 1.85 | |
AXGN | F | AxoGen, Inc. | -1.53 | |
BCDA | F | BioCardia, Inc. | 1.31 | |
BLFS | B | BioLife Solutions, Inc. | -0.72 | |
BRTX | D | BioRestorative Therapies, Inc. | -6.51 | |
CLGN | B | CollPlant Holdings, Ltd. | -3.80 | |
HBIO | F | Harvard Bioscience, Inc. | 0.79 | |
HUMA | B | Humacyte, Inc. | 0.23 | |
LSTA | D | Lisata Therapeutics, Inc. | -2.73 | |
ORGO | F | Organogenesis Holdings Inc. | 0.00 |
Related Industries: Asset Management Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices Medical Instruments & Supplies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HTEC | D | Robo Global Healthcare Technology and Innovation ETF | 1.17 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 0.83 | |
ROSC | B | Hartford Multifactor Small Cap ETF | 0.39 | |
IWC | B | iShares Microcap ETF | 0.11 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.09 |
Compare ETFs
- Regenerative Medicine
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.Some of the biomedical approaches within the field of regenerative medicine may involve the use of stem cells. Examples include the injection of stem cells or progenitor cells obtained through directed differentiation (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells (immunomodulation therapy); and transplantation of in vitro grown organs and tissues (tissue engineering).
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles